Boxer Capital focuses on investing in BioTech companies aiming to drastically improve medicine, particularly for severe medical illnesses such as oncology and rare diseases. Their approach includes investing across the entire drug development lifecycle, from early stage preclinical discovery assets to late stage clinical and commercial stage companies.